Tralokinumab: First Approval (Aug, 10.1007/s40265-021-01583-1, 2021)
Gespeichert in:
Veröffentlicht in: | Drugs (New York, N.Y.) N.Y.), 2021-10, Vol.81 (15), p.1811-1811 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1811 |
---|---|
container_issue | 15 |
container_start_page | 1811 |
container_title | Drugs (New York, N.Y.) |
container_volume | 81 |
creator | Duggan, Sean |
description | |
doi_str_mv | 10.1007/s40265-021-01598-8 |
format | Article |
fullrecord | <record><control><sourceid>webofscience</sourceid><recordid>TN_cdi_webofscience_primary_000696787900001</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>000696787900001</sourcerecordid><originalsourceid>FETCH-webofscience_primary_0006967879000013</originalsourceid><addsrcrecordid>eNqVjc1qwkAURi-lotH6Al3N0qJj7804f91JVHwA9zJKLNPGTJhJKr59Lbjsol1958CBD-CZcE6I-jUtMFeSY04cSVrDzQNkRNpyshIfIUOknCul9ACGKX38qJW2DwOxkEJoozJY7aKrwqevu7M7vLGNj6lly6aJ4ctVbLLs3mfs9z8jOM1YfrOXJ-idXJXK8X1HMN2sd8WWX8pDOKWjL-tjuW-iP7t43SOiskobbW-EJP5bm7_XhW9d60NdhK5uxTdzKFNz</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Tralokinumab: First Approval (Aug, 10.1007/s40265-021-01583-1, 2021)</title><source>Springer Journals</source><source>Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><creator>Duggan, Sean</creator><creatorcontrib>Duggan, Sean</creatorcontrib><identifier>ISSN: 0012-6667</identifier><identifier>EISSN: 1179-1950</identifier><identifier>DOI: 10.1007/s40265-021-01598-8</identifier><identifier>PMID: 34533786</identifier><identifier>PMID: 34559386</identifier><language>eng</language><publisher>NORTHCOTE: Springer Nature</publisher><subject>Life Sciences & Biomedicine ; Pharmacology & Pharmacy ; Science & Technology ; Toxicology</subject><ispartof>Drugs (New York, N.Y.), 2021-10, Vol.81 (15), p.1811-1811</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>0</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000696787900001</woscitedreferencesoriginalsourcerecordid><cites>FETCH-webofscience_primary_0006967879000013</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930,39263</link.rule.ids></links><search><creatorcontrib>Duggan, Sean</creatorcontrib><title>Tralokinumab: First Approval (Aug, 10.1007/s40265-021-01583-1, 2021)</title><title>Drugs (New York, N.Y.)</title><addtitle>DRUGS</addtitle><subject>Life Sciences & Biomedicine</subject><subject>Pharmacology & Pharmacy</subject><subject>Science & Technology</subject><subject>Toxicology</subject><issn>0012-6667</issn><issn>1179-1950</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>HGBXW</sourceid><recordid>eNqVjc1qwkAURi-lotH6Al3N0qJj7804f91JVHwA9zJKLNPGTJhJKr59Lbjsol1958CBD-CZcE6I-jUtMFeSY04cSVrDzQNkRNpyshIfIUOknCul9ACGKX38qJW2DwOxkEJoozJY7aKrwqevu7M7vLGNj6lly6aJ4ctVbLLs3mfs9z8jOM1YfrOXJ-idXJXK8X1HMN2sd8WWX8pDOKWjL-tjuW-iP7t43SOiskobbW-EJP5bm7_XhW9d60NdhK5uxTdzKFNz</recordid><startdate>20211001</startdate><enddate>20211001</enddate><creator>Duggan, Sean</creator><general>Springer Nature</general><scope>BLEPL</scope><scope>DTL</scope><scope>HGBXW</scope></search><sort><creationdate>20211001</creationdate><title>Tralokinumab: First Approval (Aug, 10.1007/s40265-021-01583-1, 2021)</title><author>Duggan, Sean</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-webofscience_primary_0006967879000013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Life Sciences & Biomedicine</topic><topic>Pharmacology & Pharmacy</topic><topic>Science & Technology</topic><topic>Toxicology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Duggan, Sean</creatorcontrib><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 2021</collection><jtitle>Drugs (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Duggan, Sean</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tralokinumab: First Approval (Aug, 10.1007/s40265-021-01583-1, 2021)</atitle><jtitle>Drugs (New York, N.Y.)</jtitle><stitle>DRUGS</stitle><date>2021-10-01</date><risdate>2021</risdate><volume>81</volume><issue>15</issue><spage>1811</spage><epage>1811</epage><pages>1811-1811</pages><issn>0012-6667</issn><eissn>1179-1950</eissn><cop>NORTHCOTE</cop><pub>Springer Nature</pub><pmid>34533786</pmid><pmid>34559386</pmid><doi>10.1007/s40265-021-01598-8</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0012-6667 |
ispartof | Drugs (New York, N.Y.), 2021-10, Vol.81 (15), p.1811-1811 |
issn | 0012-6667 1179-1950 |
language | eng |
recordid | cdi_webofscience_primary_000696787900001 |
source | Springer Journals; Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /> |
subjects | Life Sciences & Biomedicine Pharmacology & Pharmacy Science & Technology Toxicology |
title | Tralokinumab: First Approval (Aug, 10.1007/s40265-021-01583-1, 2021) |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T00%3A12%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-webofscience&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tralokinumab:%20First%20Approval%20(Aug,%2010.1007/s40265-021-01583-1,%202021)&rft.jtitle=Drugs%20(New%20York,%20N.Y.)&rft.au=Duggan,%20Sean&rft.date=2021-10-01&rft.volume=81&rft.issue=15&rft.spage=1811&rft.epage=1811&rft.pages=1811-1811&rft.issn=0012-6667&rft.eissn=1179-1950&rft_id=info:doi/10.1007/s40265-021-01598-8&rft_dat=%3Cwebofscience%3E000696787900001%3C/webofscience%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/34533786&rfr_iscdi=true |